Appili Therapeutics Inc (APLI.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,228 | 94 | 2,466 | 6,665 | 11,063 |
| Marketable Securities | N/A | N/A | N/A | 0 | 5,062 |
| Receivables | 1,671 | 1,173 | 421 | 1,391 | 1,686 |
| TOTAL | $3,014 | $1,460 | $3,118 | $8,239 | $18,262 |
| Non-Current Assets | |||||
| PPE Net | 19 | 30 | 15 | 42 | 55 |
| TOTAL | $19 | $30 | $15 | $42 | $55 |
| Total Assets | $3,033 | $1,490 | $3,132 | $8,282 | $18,317 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,558 | 7,310 | 113 | 96 | 85 |
| Accounts payable and accrued liabilities | 4,106 | 4,183 | 2,823 | 6,456 | 4,531 |
| Other current liabilities | N/A | N/A | N/A | 118 | N/A |
| TOTAL | $15,694 | $11,540 | $2,977 | $6,669 | $4,617 |
| Non-Current Liabilities | |||||
| Long Term Debt | 736 | 875 | 7,552 | 4,883 | 947 |
| TOTAL | $736 | $875 | $7,552 | $4,883 | $947 |
| Total Liabilities | $16,430 | $12,415 | $10,529 | $11,552 | $5,564 |
| Shareholders' Equity | |||||
| Common Shares | 42,323 | 42,323 | 42,323 | 39,653 | 34,962 |
| Retained earnings | -71,718 | -69,093 | -65,312 | -56,069 | -30,951 |
| Other shareholders' equity | 1,179 | 2,975 | 9,179 | 8,132 | 6,189 |
| TOTAL | $-13,397 | $-10,925 | $-7,397 | $-3,271 | $12,753 |
| Total Liabilities And Equity | $3,033 | $1,490 | $3,132 | $8,282 | $18,317 |